source
- Eli Lilly’s one-patient early access to retatrutide leaves doctors seeking answersEli Lilly granted a single 79-year-old patient special access to retatrutide, an experimental obesity drug that has shown weight‑loss results comparable to bariatric surgery. Since that decision,…
- Moderna awaits FDA decision on mRNA flu vaccine as biotech fund launches and pricing disputes intensifyModerna is awaiting the FDA's decision on its mRNA influenza vaccine, which could become the first seasonal flu shot using messenger RNA technology. Meanwhile, venture firm TCGX announced a new $4…